Taken together, our results suggest that SRSF9 acts as an m6A-binding protein by recognizing and binding the m6A modification sites of DSN1 transcripts to enhance the stability of DSN1 mRNA in CRC cells. The gene discussed is DSN1; the disease is colorectal carcinoma.